Detection of Viral Proteins in Rabies Virus-Infected Mouse Brain Tissue
JoVE Encyclopedia of Experiments
Neuroscience
0 views • 1:28 min • March 4th, 2025
Collect fixed brain sections from intracerebral rabies virus-infected mice at defined postmortem intervals.
The virus infects pyramidal neurons in the cerebral cortex, and expressed viral proteins localize within intracytoplasmic granular structures known as inclusion bodies.
Treat the sections with ammonium chloride to neutralize fixation-induced reactive groups and minimize background staining.
Immerse the sections in hydrogen peroxide to inactivate endogenous peroxidase and reduce nonspecific signals.
Apply a blocking solution containing a detergent to permeabilize cellular membranes and mask nonspecific binding sites.
Incubate with primary antibodies specific to the viral proteins.
Wash and incubate with biotin-conjugated secondary antibodies that bind to the primary antibodies.
Wash again and introduce peroxidase enzyme-conjugated avidin, which binds to biotin, followed by a chromogenic substrate that the enzyme converts into a colored product.
Visualize the immunoreactive inclusion bodies containing viral proteins using a microscope.
With an increase in postmortem time, neuronal degradation and the disappearance of inclusion bodies become evident.
Overview
This study investigates the localization of rabies virus proteins in infected mouse brain sections. It details the immunohistochemical techniques used to visualize viral inclusion bodies in neurons.
Key Study Components
Area of Science
- Neuroscience
- Virology
- Immunohistochemistry
Background
- Rabies virus infects neurons, particularly pyramidal cells in the cerebral cortex.
- Inclusion bodies are formed as viral proteins aggregate within infected cells.
- Understanding the viral protein localization can provide insights into the pathogenesis of rabies.
- Immunohistochemical techniques are essential for visualizing these proteins in fixed tissue.
Purpose of Study
- To visualize the localization of rabies virus proteins in infected neurons.
- To assess the impact of postmortem intervals on neuronal integrity and viral protein visibility.
- To refine immunohistochemical methods for better detection of viral proteins.
Methods Used
- Collection of fixed brain sections from rabies virus-infected mice.
- Treatment with ammonium chloride to reduce background staining.
- Use of hydrogen peroxide to inactivate endogenous peroxidase.
- Application of primary and secondary antibodies for specific viral protein detection.
Main Results
- Immunoreactive inclusion bodies were successfully visualized in the brain sections.
- Neuronal degradation and loss of inclusion bodies were observed with increased postmortem time.
- The methods employed minimized nonspecific signals, enhancing the clarity of results.
Conclusions
- The study provides a reliable method for visualizing rabies virus proteins in brain tissue.
- Findings highlight the effects of postmortem intervals on neuronal integrity.
- This research contributes to understanding the pathogenesis of rabies virus infection.
Frequently Asked Questions
Executive Industry Relevance
This method enables visualization of viral protein localization in neuronal tissue, supporting target validation in antiviral discovery. It provides a mechanistic readout for assessing compound effects on viral protein expression and inclusion body formation. The approach aids in de-risking early-stage antiviral candidates by linking target engagement to observable histopathological changes in a disease-relevant system.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of viral protein expression patterns in infected neurons.
- Operational Value: Supports functional validation of antiviral targets through histopathological correlation.
- Predictive Value: Facilitates assessment of target modulation via inclusion body dynamics as a phenotypic readout.
Screening & Assay Development
- Assay Readiness: Generates standardized, reproducible tissue sections for compound screening campaigns.
- Quantitative Output: Enables measurement of inclusion body intensity and distribution as a biomarker of viral protein expression.
- Scalability: Compatible with high-content imaging platforms for multiplexed target engagement analysis.
Translational & Preclinical Research
- Disease Relevance: Uses rabies-infected mouse brain as a model for neurotropic viral pathogenesis.
- Translational Continuity: Bridges in vitro findings to in vivo-like tissue context for target validation.
- Mechanistic De-risking: Links compound treatment to changes in viral protein aggregation and neuronal integrity.
Pipeline & Workflow Integration
The method fits within the antiviral discovery continuum from target engagement to phenotypic screening and preclinical validation.
- Discovery Biology: Supports hypothesis testing on viral protein localization and aggregation in neurons.
- Screening: Enables compound evaluation via immunohistochemical readouts of viral protein expression.
- Analytics: Provides quantitative imaging data on inclusion body formation to assess target modulation.
- Translational Research: Connects molecular target effects to histopathological outcomes in a disease-relevant system.
- Enterprise Reuse: Establishes a reusable histopathological platform for neurotropic virus target validation.
Operational & Enterprise Impact
- Scientific Value: Enhances target confidence through direct visualization of viral protein expression in neurons.
- Operational Value: Delivers standardized, low-background staining for reproducible results across studies.
- Strategic Value: Improves go/no-go decisions by linking target engagement to phenotypic changes in tissue.
- Portfolio Impact: Enables risk-adjusted prioritization of antiviral candidates based on target modulation in brain tissue.
Implementation Considerations
- Requires expertise in immunohistochemistry and neuropathology for accurate interpretation.
- Dependent on access to cryostat or microtome for sectioning fixed brain tissue.
- Necessitates validation of antibody specificity to avoid cross-reactivity in complex tissue.
- Involves optimization of blocking and permeabilization steps to minimize background in neuronal sections.
- Limited by postmortem interval effects on tissue integrity, requiring standardized timing for reproducible outcomes.
Biopharma FAQs
Determination of Protein Expression Level in Cultured Cells by Immunocytochemistry on Paraffin-embedded Cell Blocks
Related Videos
0 Views
Live-3D-Cell Immunocytochemistry Assays of Pediatric Diffuse Midline Glioma
Related Videos
0 Views
Detection of Misfolded Prion Protein Aggregates in Mouse Brain Tissue Using Western Blotting
Related Videos
0 Views
An Immunohistochemistry Staining for the Detection of Rabies Virus Antigens
Related Videos
0 Views
Three-Dimensional Visualization of a Rabies Virus Infection in Mouse Brain Tissue
Related Videos
0 Views
High-Resolution 3D Imaging of Rabies Virus Infection in Solvent-Cleared Brain Tissue
Related Videos
0 Views
Enhanced Rabies Surveillance Using a Direct Rapid Immunohistochemical Test
Related Videos
0 Views
Evaluation of a Universal Nested Reverse Transcription Polymerase Chain Reaction for the Detection of Lyssaviruses
Related Videos
0 Views
Field Postmortem Rabies Rapid Immunochromatographic Diagnostic Test for Resource-Limited Settings with Further Molecular Applications
Related Videos
0 Views
Immunohistochemistry Test for the Lyssavirus Antigen Detection from Formalin-Fixed Tissues
Related Videos
0 Views
Last updated: 29 August 2026